<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-152552</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Dual antiplatelet therapy beyond 1 year postinfarction: the time has come and we&#146;re beginning to know who will benefit</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Ruiz-Nodar,  Juan M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev Esp Cardiol;69(5): 471-473, mayo 2016. graf</dc:source>
<dc:identifier>ibc-152552</dc:identifier>
<dc:title xml:lang="es">Doble antiagregación más allá del año tras el infarto: ha llegado el momento y empezamos a conocer para qué pacientes</dc:title>
<dc:subject>^d29633</dc:subject>
<dc:subject>^d32095</dc:subject>
<dc:subject>^d22965^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9395^s22057</dc:subject>
<dc:subject>^d51716</dc:subject>
<dc:type>article</dc:type>
<dc:date>201605</dc:date>
</metadata>
</record>
</ibecs-document>
